AstraZeneca’s Executive Shakeup Includes Global Strategist To Be Named Later

16 Jan 2013

• By Sten Stovall

AstraZeneca's new CEO Pascal Soriot signaled significant change is afoot for the troubled drug maker by eliminating the jobs of R&D President Martin Mackay and Exec VP-Global Commercial Tony Zook.

AstraZeneca’s Executive Shakeup Includes Global Strategist To Be Named Later

More from United Kingdom

More from Europe